Proton pump inhibitors use suppresses iron absorption in congenital dyserythropoietic anemia.

about

Proton pump inhibitors use suppresses iron absorption in congenital dyserythropoietic anemia.

Item

http://www.wikidata.org/entity/Q51269698

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@en

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@nl

type

Item

label

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@en

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@nl

prefLabel

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@en

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@nl

P1476

Proton pump inhibitors use sup ...... ital dyserythropoietic anemia.

@en

P2093

Abed Abu Quider

http://www.w3.org/2001/XMLSchema#string

Hanna Shalev

http://www.w3.org/2001/XMLSchema#string

Josef Kapelushnik

http://www.w3.org/2001/XMLSchema#string

Miriam Ben Harosh

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in the understanding of the congenital dyserythropoietic anaemias.

Iron-chelating therapy for transfusional iron overload

Physiology and molecular biology of dietary iron absorption.

Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.

Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole.

The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.

Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia.

Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation.

P304

457-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08880018.2016.1247392

http://www.w3.org/2001/XMLSchema#string

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27960647

http://www.w3.org/2001/XMLSchema#string